Vitamin D Deficiency (Adults) - Osteomalacia

Overview


Plain-Language Overview

Vitamin D Deficiency (Adults) - Osteomalacia is a condition where the bones become soft and weak due to a lack of vitamin D, which is essential for healthy bone formation. This condition affects the skeletal system and can cause symptoms like bone pain, muscle weakness, and increased risk of fractures. Vitamin D helps the body absorb calcium and phosphorus, minerals critical for strong bones. Without enough vitamin D, bones lose their strength and flexibility, leading to discomfort and difficulty with movement. It often develops slowly and may be linked to poor diet, limited sun exposure, or problems with vitamin D metabolism.

Clinical Definition

Vitamin D Deficiency (Adults) - Osteomalacia is characterized by defective bone mineralization due to inadequate levels of 25-hydroxyvitamin D, leading to accumulation of unmineralized osteoid. The core pathology involves impaired intestinal absorption of calcium and phosphorus, resulting in hypocalcemia and secondary hyperparathyroidism. This causes increased bone resorption and defective bone remodeling. The usual causes include insufficient dietary intake, inadequate sunlight exposure, malabsorption syndromes, or chronic kidney disease affecting vitamin D metabolism. Clinically, it presents with diffuse bone pain, proximal muscle weakness, and increased susceptibility to fractures. Laboratory findings typically show low serum 25(OH)D, low or normal calcium, low phosphorus, elevated alkaline phosphatase, and secondary hyperparathyroidism. Radiographs may reveal pseudofractures or Looser zones, which are pathognomonic.

Inciting Event

  • Prolonged vitamin D deficiency from inadequate dietary intake or sunlight exposure.

  • Malabsorption of vitamin D due to gastrointestinal diseases or surgeries.

  • Chronic renal insufficiency impairing 1-alpha hydroxylase activity.

  • Medications inducing vitamin D metabolism such as anticonvulsants or glucocorticoids.

Latency Period

  • Months to years of sustained vitamin D deficiency are typically required before clinical osteomalacia develops.

  • Gradual onset of symptoms occurs as bone demineralization progresses.

  • Symptom onset may be delayed in patients with partial vitamin D deficiency or intermittent exposure.

Diagnostic Delay

  • Nonspecific symptoms such as diffuse bone pain and muscle weakness often mimic other musculoskeletal disorders.

  • Normal or mildly decreased serum calcium can mislead clinicians away from vitamin D deficiency.

  • Lack of routine vitamin D level testing in patients with bone pain delays diagnosis.

  • Radiographic changes may be subtle or absent early in disease, leading to missed diagnosis.

Clinical Presentation


Signs & Symptoms

  • Diffuse bone pain and tenderness, often worse at night

  • Muscle weakness, especially proximal muscles

  • Difficulty walking and frequent falls

  • Fractures with minimal trauma

  • Fatigue and generalized malaise

History of Present Illness

  • Progressive diffuse bone pain, especially in the lower back, hips, and legs.

  • Proximal muscle weakness causing difficulty climbing stairs or rising from a chair.

  • Fatigue and generalized weakness develop insidiously over months.

  • History of fractures or skeletal deformities may be present in advanced cases.

Past Medical History

  • History of malabsorptive disorders such as celiac disease or bariatric surgery.

  • Chronic kidney or liver disease impairing vitamin D metabolism.

  • Use of medications like anticonvulsants or glucocorticoids that affect vitamin D levels.

  • Previous fractures or bone pain suggestive of underlying metabolic bone disease.

Family History

  • Usually negative for inherited bone disorders as osteomalacia is primarily acquired.

  • Rare familial forms of vitamin D–dependent rickets may be considered if early onset occurs.

  • No consistent familial pattern in typical adult osteomalacia cases.

Physical Exam Findings

  • Bone tenderness on palpation, especially over the ribs, pelvis, and long bones

  • Proximal muscle weakness with difficulty rising from a chair or climbing stairs

  • Waddling gait due to hip girdle muscle weakness

  • Skeletal deformities such as bowing of the legs or pelvic deformities in severe cases

  • Fractures with minimal trauma, often involving ribs, femur, or vertebrae

Diagnostic Workup


Diagnostic Criteria

Diagnosis is established by demonstrating low serum 25-hydroxyvitamin D levels combined with clinical features of bone pain and muscle weakness. Laboratory tests show low or normal serum calcium, low phosphorus, elevated alkaline phosphatase, and elevated parathyroid hormone due to secondary hyperparathyroidism. Radiographic evidence of Looser zones (pseudofractures) supports the diagnosis. Bone biopsy with tetracycline labeling can confirm defective mineralization if diagnosis is uncertain.

Pathophysiology


Key Mechanisms

  • Decreased intestinal absorption of calcium due to low serum 1,25-dihydroxyvitamin D levels impairs bone mineralization.

  • Secondary hyperparathyroidism develops as a compensatory response to hypocalcemia, increasing bone resorption.

  • Defective mineralization of osteoid matrix leads to accumulation of unmineralized bone, causing osteomalacia.

  • Hypophosphatemia results from increased renal phosphate wasting driven by elevated parathyroid hormone.

InvolvementDetails
Organs

Kidneys convert 25-hydroxyvitamin D to active 1,25-dihydroxyvitamin D, a critical step impaired in some causes of osteomalacia.

Parathyroid glands secrete PTH in response to hypocalcemia caused by vitamin D deficiency, exacerbating bone resorption.

Skin synthesizes vitamin D3 upon ultraviolet B radiation exposure, initiating vitamin D metabolism.

Tissues

Bone tissue exhibits defective mineralization in osteomalacia, leading to softening and increased fracture risk.

Intestinal mucosa is the site of vitamin D–mediated calcium absorption, which is impaired in deficiency states.

Cells

Osteoblasts are responsible for bone formation and are stimulated by active vitamin D to mineralize osteoid.

Osteoclasts resorb bone and are indirectly regulated by vitamin D through calcium and phosphate homeostasis.

Chemical Mediators

1,25-dihydroxyvitamin D (Calcitriol) is the active form of vitamin D that increases intestinal calcium absorption and bone mineralization.

Parathyroid hormone (PTH) is elevated in vitamin D deficiency, promoting bone resorption to maintain serum calcium.

Alkaline phosphatase is elevated in osteomalacia due to increased osteoblastic activity during defective bone mineralization.

Treatments


Pharmacological Treatments

  • Vitamin D3 (Cholecalciferol) or Vitamin D2 (Ergocalciferol)

    • Mechanism:
      • Restores serum 25-hydroxyvitamin D levels to enhance intestinal calcium absorption and bone mineralization.

    • Side effects:
      • Hypercalcemia

      • Hypercalciuria

      • Nephrolithiasis

    • Clinical role:
      • First-line

  • Calcium supplementation

    • Mechanism:
      • Provides essential calcium to support bone mineralization alongside vitamin D therapy.

    • Side effects:
      • Constipation

      • Hypercalcemia

      • Kidney stones

    • Clinical role:
      • Adjunctive

Non-pharmacological Treatments

  • Increase safe sunlight exposure to promote endogenous vitamin D synthesis in the skin.

  • Implement dietary modifications to include calcium-rich foods such as dairy products and leafy greens.

  • Encourage weight-bearing exercise to improve bone strength and reduce fracture risk.

Prevention


Pharmacological Prevention

  • Vitamin D3 (cholecalciferol) supplementation to maintain adequate serum levels

  • Calcium supplementation to support bone mineralization

  • Active vitamin D analogs (calcitriol) in cases of renal impairment

  • Monitoring and adjusting doses in patients on anticonvulsants

  • Regular serum 25-hydroxyvitamin D level checks to guide therapy

Non-pharmacological Prevention

  • Adequate sunlight exposure to promote endogenous vitamin D synthesis

  • Diet rich in vitamin D and calcium including fortified foods and fatty fish

  • Screening high-risk populations such as elderly and malabsorptive disorders

  • Weight-bearing exercises to strengthen bones and muscles

  • Avoidance of factors impairing vitamin D metabolism such as excessive alcohol

Outcome & Complications


Complications

  • Pathologic fractures leading to disability

  • Severe muscle weakness causing falls and injury

  • Skeletal deformities impairing mobility

  • Secondary hyperparathyroidism causing bone resorption

  • Chronic pain syndrome with reduced quality of life

Short-term Sequelae Long-term Sequelae
  • Increased bone pain and muscle weakness shortly after deficiency onset

  • Difficulty with weight-bearing activities

  • Elevated PTH causing transient hypophosphatemia

  • Early Looser zones visible on imaging

  • Increased risk of falls due to muscle weakness

  • Permanent skeletal deformities such as bowed legs or pelvic abnormalities

  • Chronic fractures and nonunion

  • Persistent muscle weakness and gait abnormalities

  • Osteoporosis secondary to prolonged bone demineralization

  • Reduced mobility and increased dependency

Differential Diagnoses


Vitamin D Deficiency (Adults) - Osteomalacia versus Primary Hyperparathyroidism

Vitamin D Deficiency (Adults) - Osteomalacia

Primary Hyperparathyroidism

Low or normal serum calcium with elevated PTH due to secondary hyperparathyroidism

Elevated serum calcium with elevated or inappropriately normal parathyroid hormone (PTH)

Bone softening due to defective mineralization without hypercalcemia

Chronic hypercalcemia leading to bone resorption and kidney stones

Looser zones (pseudofractures) and generalized osteopenia on X-ray

Osteitis fibrosa cystica with subperiosteal bone resorption on X-ray

Vitamin D Deficiency (Adults) - Osteomalacia versus Hypophosphatasia

Vitamin D Deficiency (Adults) - Osteomalacia

Hypophosphatasia

Elevated serum alkaline phosphatase due to increased osteoblastic activity

Low serum alkaline phosphatase (ALP) activity

Low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels

Genetic testing showing mutations in ALPL gene

Acquired deficiency due to nutritional or malabsorptive causes

Inherited disorder with variable onset from infancy to adulthood

Vitamin D Deficiency (Adults) - Osteomalacia versus Renal Osteodystrophy

Vitamin D Deficiency (Adults) - Osteomalacia

Renal Osteodystrophy

No history of renal impairment

History of chronic kidney disease or dialysis

Low serum phosphate with elevated PTH secondary to vitamin D deficiency

Elevated serum phosphate and PTH with low or normal calcium

Predominant osteomalacia with defective mineralization on biopsy

Mixed osteitis fibrosa and osteomalacia features on bone biopsy

Vitamin D Deficiency (Adults) - Osteomalacia versus Osteoporosis

Vitamin D Deficiency (Adults) - Osteomalacia

Osteoporosis

Low serum 25-hydroxyvitamin D and elevated alkaline phosphatase

Normal serum calcium, phosphate, and alkaline phosphatase

Defective bone mineralization causing bone softening

Progressive loss of bone mass without defective mineralization

Presence of Looser zones (pseudofractures) on X-ray

Reduced bone density without Looser zones or pseudofractures

Vitamin D Deficiency (Adults) - Osteomalacia versus Paget Disease of Bone

Vitamin D Deficiency (Adults) - Osteomalacia

Paget Disease of Bone

Elevated alkaline phosphatase with low calcium and phosphate

Markedly elevated alkaline phosphatase with normal calcium and phosphate

Looser zones and generalized osteopenia without bone expansion

Thickened, disorganized bone with cortical thickening and bone expansion

Diffuse bone softening due to defective mineralization

Focal bone disease with increased bone turnover

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.